Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2010-2014
Title: Klaus G Reymann: Innovator in Neurodiagnostics and Neurotherapeutics
Introduction
Klaus G Reymann is a notable inventor based in Niederndodeleben, Germany. He has made significant contributions to the field of neurodiagnostics and neurotherapeutics, holding 2 patents that focus on innovative methods for analyzing metabolic processes in the brain.
Latest Patents
Reymann's latest patents include a diagnostic substance and method for the analysis of metabolism processes in the brain. This invention involves a diagnostic substance that contains a complex of lipophilic anions and metal ions, which are crucial for investigating metabolic processes in the brain and central nervous system. His second patent pertains to a drug preparation that combines α-lipoic acid, ambroxol, and inhibitors of the angiotensin-converting enzyme (ACE) for the treatment of neurodegenerative diseases. This composition aims to provide both prevention and therapy for such conditions.
Career Highlights
Throughout his career, Klaus G Reymann has worked with several prominent organizations, including Keyneurotek Pharmaceuticals AG and the Leibniz Institute for Neurobiology. His work in these institutions has allowed him to advance his research and contribute to the development of innovative therapeutic solutions.
Collaborations
Reymann has collaborated with notable colleagues such as Peter Röhnert and Frank Striggow, further enhancing his research and development efforts in the field of neurobiology.
Conclusion
Klaus G Reymann's contributions to neurodiagnostics and neurotherapeutics highlight his innovative spirit and dedication to advancing medical science. His patents reflect a commitment to improving the understanding and treatment of neurodegenerative diseases.